Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hologic to Acquire Mammography Technology

By HospiMedica staff writers
Posted on 05 Jul 2005
Hologic (Bedford, MA, USA), a provider of diagnostic imaging and digital imaging systems geared toward women's health, has entered into a definitive agreement to acquire the intellectual property of Fischer Imaging Corp. (Denver, CO, USA) related to its mammography business and products, including the rights to its SenoScan digital mammography and MammoTest stereotactic breast biopsy systems. Fischer Imaging designs, manufactures, and markets medical imaging systems for the diagnosis of breast cancer.

Hologic, under the terms of the agreement, has agreed to purchase the mammography intellectual property for a cash purchase price of US$32 million. "Expanding our market share in women's health is a key element in the growth of our company,” said Jack Cumming, chairman and CEO, Hologic. "The acquisition of these technologies is consistent with the company's strategy of looking to the future and building upon our established technology road map. Through a planned approach of ongoing technological advances and acquiring some of the best intellectual property in the field, Hologic has been able to offer innovative solutions to our customers. We believe this acquisition provides us with additional technical capabilities and customer relationships to further solidify our position of strength in the growing mammography market.”





Related Links:
Hologic
Fischer Imaging
Medical Radiographic X-Ray Machine
TR30N HF
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Pocket Fetal Doppler
CONTEC10C/CL
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.